Cargando…

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

Severe Acute Respiratory Syndrome related to Coronavirus-2 (SARS-CoV-2), coronavirus disease-2019 (COVID-19) may cause severe illness in 20% of patients. This may be in part due to an uncontrolled immune-response to SARS-CoV-2 infection triggering a systemic hyperinflammatory response, the so-called...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alijotas-Reig, Jaume, Esteve-Valverde, Enrique, Belizna, Cristina, Selva-O'Callaghan, Albert, Pardos-Gea, Josep, Quintana, Angela, Mekinian, Arsene, Anunciacion-Llunell, Ariadna, Miró-Mur, Francesc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier B.V. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252146/ https://www.ncbi.nlm.nih.gov/pubmed/32376394 http://dx.doi.org/10.1016/j.autrev.2020.102569

Ejemplares similares

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
por: Alijotas-Reig, Jaume, et al.
Publicado: (2022)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
por: Anunciación-Llunell, Ariadna, et al.
Publicado: (2022)

Thrombosis and Hyperinflammation in COVID-19 Acute Phase Are Related to Anti-Phosphatidylserine and Anti-Phosphatidylinositol Antibody Positivity
por: Alijotas-Reig, Jaume, et al.
Publicado: (2023)

TNFα-senescence initiates a STAT-dependent positive feedback loop, leading to a sustained interferon signature, DNA damage, and cytokine secretion
por: Kandhaya-Pillai, Renuka, et al.
Publicado: (2017)

Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies
por: Mahler, Michael, et al.
Publicado: (2021)

Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex
por: Kandhaya-Pillai, Renuka, et al.
Publicado: (2023)

Immunological and physiopathological approach of COVID-19 in pregnancy
por: Ferrer-Oliveras, Raquel, et al.
Publicado: (2021)

Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review
por: Muñoz, Candido Muñoz, et al.
Publicado: (2022)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia()
por: Sanchez-Pernaute, Olga, et al.
Publicado: (2021)

Inflammatory immune‐mediated adverse reactions induced by COVID‐19 vaccines in previously injected patients with soft tissue fillers: A case series of 20 patients
por: Alijotas‐Reig, Jaume, et al.
Publicado: (2022)

Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study
por: Abisror, Noemie, et al.
Publicado: (2020)

Immunomodulatory therapies for COVID-19
por: Mathur, Poonam, et al.
Publicado: (2022)

Immunopathogenesis and immunomodulatory therapy for myocarditis
por: He, Wu, et al.
Publicado: (2023)

Seminal papers in urology: anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence
por: Shugg, Nathan, et al.
Publicado: (2023)

Pharmaco-Immunomodulatory Therapy in COVID-19
por: Rizk, John G., et al.
Publicado: (2020)

Novel Immunomodulatory Therapies for Respiratory Pathologies
por: Tavares, Luciana Pádua, et al.
Publicado: (2022)

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
por: Kuwana, Masataka, et al.
Publicado: (2021)

Covid-19 and autoimmunity
por: Ehrenfeld, Michael, et al.
Publicado: (2020)

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections
por: Faura, Júlia, et al.
Publicado: (2021)

Towards gene therapy for primary ciliary dyskinesia
por: Munye, M, et al.
Publicado: (2012)

Microglia Activation and Immunomodulatory Therapies for Retinal Degenerations
por: Rashid, Khalid, et al.
Publicado: (2018)

Systematic review of immunomodulatory therapies for hidradenitis suppurativa
por: Lim, Shi Yu Derek, et al.
Publicado: (2019)

Tick Salivary Compounds for Targeted Immunomodulatory Therapy
por: Aounallah, Hajer, et al.
Publicado: (2020)

Disseminated molluscum contagiosum associated with immunomodulatory therapy
por: Wetzel, Megan, et al.
Publicado: (2020)

Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Vrachatis, Dimitrios A., et al.
Publicado: (2020)

Inflammation and Wnt Signaling: Target for Immunomodulatory Therapy?
por: Jridi, Imen, et al.
Publicado: (2021)

The immunomodulatory effects of endocrine therapy in breast cancer
por: Huang, Huanhuan, et al.
Publicado: (2021)

Androgen deprivation therapy in unlikely to be effective for treatment of COVID-19
por: O'Callaghan, M.E., et al.
Publicado: (2020)

Adherence to reporting guidelines increases the number of citations: the argument for including a methodologist in the editorial process and peer-review
por: Vilaró, Marta, et al.
Publicado: (2019)

Commentary: ‘Case Report: A Rare Case of Elderly-Onset Adult Onset Still’s Disease in a Patient With Systemic Lupus Erythematous’
por: Delplanque, Marion, et al.
Publicado: (2022)

Response letter to “Latent class analysis of 216 patients with adult-onset Still’s disease” by Sugiyama et al.
por: Delplanque, Marion, et al.
Publicado: (2022)

Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's View
por: Nahm, Dong-Ho
Publicado: (2015)

The cytokine storm of severe influenza and development of immunomodulatory therapy
por: Liu, Qiang, et al.
Publicado: (2016)

Adjunctive therapies and immunomodulatory agents in the management of severe influenza
por: Hui, David S., et al.
Publicado: (2013)

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

Nanomaterials Enhance the Immunomodulatory Effect of Molecular Targeted Therapy
por: Li, Zhongmin, et al.
Publicado: (2021)

Immunomodulatory Effects of Cell Therapy after Myocardial Infarction
por: Moore, Joseph B, et al.
Publicado: (2021)

Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
por: Braun, Lukas M., et al.
Publicado: (2021)

Irreversible Electroporation: An Emerging Immunomodulatory Therapy on Solid Tumors
por: Zhang, Nana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_96kcrkmko6r6m1s4shjsk6r8na